Substance Use Stigma, Primary Care, and the New York State Prescription Drug Monitoring Program

Reference

• Guy GP, Jr, Zhang K, Bohm MK, et al. Vital signs: changes in opioid prescribing in the United States, 2006–2015. MMWR Morb Mortal Wkly Rep. 2017;66(26):697–704.
   PubMed Web of Science ®Google Scholar
• Hedegaard H, Warner M, Miniño AM. Drug Overdose Deaths in the United States, 1999–2016. NCHS Data Brief, No. 294. Hyattsville, MD: National Center for Health Statistics. 2017.
   Google Scholar
• Knight KR, Kushel M, Chang JS, et al. Opioid pharmacovigilance: a clinical-social history of the changes in opioid prescribing for patients with co-occurring chronic non-cancer pain and substance use. Soc Sci Med. 2017;186:87–95.
   PubMed Web of Science ®Google Scholar
• Vozoris NT. The need for greater opioid pharmacovigilance in COPD. Int J Chron Obstruct Pulmon Dis. 2017;12:189–192.
   PubMed Web of Science ®Google Scholar
• Brandeis University, Prescription Drug Monitoring Program Training and Technical Assistance Center. Status of Prescription Drug Monitoring Programs. pdmpassist.org. http://www.pdmpassist.org/pdf/PDMP_Program_Status_20170824.pdf. Published August 24, 2017. Accessed July 18, 2018.
   Google Scholar
• Finklea K, Sacco LN, Bagalman E. Prescription Drug Monitoring Programs. R42593. Washington, DC: Congressional Research Service; 2014.
   Google Scholar
• Brandeis University, Prescription Drug Monitoring Program Training and Technical Assistance Center. PDMP Mandatory Enrollment of Prescribers and Dispensers. pdmpassist.org. http://www.pdmpassist.org/pdf/Mandatory_Enrollment_20180417a.pdf. Published April 20, 2018. Accessed July 18, 2018.
   Google Scholar
• Brady JE, Wunsch H, DiMaggio C, Lang BH, Giglio J, Li G. Prescription drug monitoring and dispensing of prescription opioids. Public Health Rep. 2014;129(2):139–147.
   PubMed Web of Science ®Google Scholar
• Bao Y, Pan Y, Taylor A, et al. Prescription drug monitoring programs are associated with sustained reductions in opioid prescribing by physicians. Health Aff. 2016;35(6):1045–1051.
   PubMed Web of Science ®Google Scholar
• Chang HY, Lyapustina T, Rutkow L, et al. Impact of prescription drug monitoring programs and pill mill laws on high-risk opioid prescribers: a comparative interrupted time series analysis. Drug Alcohol Depend. 2016;165:1–8.
   PubMed Web of Science ®Google Scholar
• Ali MM, Dowd WN, Classen T, Mutter R, Novak SP. Prescription drug monitoring programs, nonmedical use of prescription drugs, and heroin use: evidence from the National Survey of Drug Use and Health. Addict Behav. 2017;69:65–77.
   PubMed Web of Science ®Google Scholar
• Lin HC, Wang Z, Boyd C, Simoni-Wastila L, Buu A. Associations between statewide prescription drug monitoring program (PDMP) requirement and physician patterns of prescribing opioid analgesics for patients with non-cancer chronic pain. Addict Behav. 2018;76:348–354.
   PubMed Web of Science ®Google Scholar
• Irvine JM, Hallvik SE, Hildebran C, Marino M, Beran T, Deyo RA. Who uses a prescription drug monitoring program and how? Insights from a statewide survey of Oregon clinicians. J Pain. 2014;15(7):747–755.
   PubMed Web of Science ®Google Scholar
• Young HW, Tyndall JA, Cottler LB. The current utilization and perceptions of prescription drug monitoring programs among emergency medicine providers in Florida. Int J Emerg Med. 2017;10(1):16.
   PubMedGoogle Scholar
• Hildebran C, Cohen DJ, Irvine JM, et al. How clinicians use prescription drug monitoring programs: a qualitative inquiry. Pain Med. 2014;15(7):1179–1186.
   PubMed Web of Science ®Google Scholar
• Leichtling GJ, Irvine JM, Hildebran C, Cohen DJ, Hallvik SE, Deyo RA. Clinicians' use of prescription drug monitoring programs in clinical practice and decision-making. Pain Med. 2017;18(6):1063–1069.
   PubMed Web of Science ®Google Scholar
• Hildebran C, Leichtling G, Irvine JM, Cohen DJ, Hallvik SE, Deyo RA. Clinical styles and practice policies: influence on communication with patients regarding worrisome prescription drug monitoring program data. Pain Med. 2016;17(11):2061–2066.
   PubMed Web of Science ®Google Scholar
• Carnes NA, Wright ER, Norwood CW. A qualitative analysis of prescribers' and dispensers' views on improving prescription drug monitoring programs. Res Social Adm Pharm. 2016;13(6):1167–1174
   PubMed Web of Science ®Google Scholar
• Internet System for Tracking Over-Prescribing. (2013). Pub. L. No. 3343–a.
   Google Scholar
• Rasubala L, Pernapati L, Velasquez X, Burk J, Ren YF. Impact of a mandatory prescription drug monitoring program on prescription of opioid analgesics by dentists. PLoS One. 2015;10(8):e0135957
   PubMed Web of Science ®Google Scholar
• Brown R, Riley MR, Ulrich L, et al. Impact of New York prescription drug monitoring program, I-STOP, on statewide overdose morbidity. Drug Alcohol Depend. 2017;178:348–354.
   PubMed Web of Science ®Google Scholar
• Blum CJ, Nelson LS, Hoffman RS. A survey of physicians' perspectives on the New York State Mandatory Prescription Monitoring Program (ISTOP). J Subst Abuse Treat. 2016;70:35–43.
   PubMed Web of Science ®Google Scholar
• Jawhari B, Keenan L, Zakus D, et al. Barriers and facilitators to Electronic Medical Record (EMR) use in an urban slum. Int J Med Inform. 2016;94:246–254.
   PubMed Web of Science ®Google Scholar
• Hinojosa-Amaya JM, Rodríguez-García FG, Yeverino-Castro SG, Sánchez-Cárdenas M, Villarreal-Alarcón MÁ, Galarza-Delgado DÁ. Medication errors: electronic vs. paper-based prescribing. Experience at a tertiary care university hospital. J Eval Clin Pract. 2016;22(5):751–754.
   PubMed Web of Science ®Google Scholar
• Villaseñor S, Walker T, Fetters L, Mccoy M. e-Prescribing in the acute care setting: determining the educational and motivational needs of healthcare providers. Comput Inform Nurs. 2017;35(8):392–400.
   PubMed Web of Science ®Google Scholar
• Tuot DS, Leeds K, Murphy EJ, et al. Facilitators and barriers to implementing electronic referral and/or consultation systems: a qualitative study of 16 health organizations. BMC Health Serv Res 2015;15:568
   PubMed Web of Science ®Google Scholar
• Chen HT, Grimley DM, Waithaka Y, Aban IB, Hu J, Bachmann LH. A process evaluation of the implementation of a computer-based, health provider-delivered HIV-prevention intervention for HIV-positive men who have sex with men in the primary care setting. AIDS Care. 2008;20(1):51–60.
   PubMed Web of Science ®Google Scholar
• Fareed N, Bazzoli GJ, Farnsworth Mick SS, Harless DW. The influence of institutional pressures on hospital electronic health record presence. Soc Sci Med. 2015;133:28–35.
   PubMed Web of Science ®Google Scholar
• Mwachofi AK, Khaliq AA, Carrillo ER, Winfree W. Technology versus humanism: how patients perceive the use of electronic health records in physicians' offices–a qualitative study. Health Commun. 2016;31(3):257–264.
   PubMed Web of Science ®Google Scholar
• Reich A. Disciplined doctors: the electronic medical record and physicians' changing relationship to medical knowledge. Soc Sci Med. 2012;74(7):1021–1028.
   PubMed Web of Science ®Google Scholar
• Hatcher AE, Mendoza S, Hansen H. At the expense of a life: race, class, and the meaning of buprenorphine in pharmaceuticalized “Care”. Subst Use Misuse. 2018;53(2):301–310.
   PubMed Web of Science ®Google Scholar
• Richman LS, Lattanner MR. Self-regulatory processes underlying structural stigma and health. Soc Sci Med. 2014;103:94–100.
   PubMed Web of Science ®Google Scholar
• Phelan JC, Lucas JW, Ridgeway CL, Taylor CJ. Stigma, status, and population health. Soc Sci Med. 2014;103:15–23.
   PubMed Web of Science ®Google Scholar
• Link BG, Phelan J. Stigma power. Soc Sci Med. 2014;103:24–32.
   PubMed Web of Science ®Google Scholar
• Kennedy-Hendricks A, Busch SH, McGinty EE, et al. Primary care physicians' perspectives on the prescription opioid epidemic. Drug Alcohol Depend. 2016;165:61–70.
   PubMed Web of Science ®Google Scholar
• Van Boekel LC, Brouwers EP, Van Weeghel J, Garretsen HF. Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review. Drug Alcohol Depend. 2013;131(1-2):23–35.
   PubMed Web of Science ®Google Scholar
• Kennedy-Hendricks A, Barry CL, Gollust SE, Ensminger ME, Chisolm MS, McGinty EE. Social stigma toward persons with prescription opioid use disorder: associations with public support for punitive and public health-oriented policies. Psychiatr Serv. 2017;68(5):462–469.
   PubMed Web of Science ®Google Scholar
• Storholm ED, Ober AJ, Hunter SB, et al. Barriers to integrating the continuum of care for opioid and alcohol use disorders in primary care: a qualitative longitudinal study. J Subst Abuse Treat. 2017;83:45–54. 10.1016/j.jsat.2017.09.015.
   PubMed Web of Science ®Google Scholar
• Krebs EE, Bergman AA, Coffing JM, Campbell SR, Frankel RM, Matthias MS. Barriers to guideline-concordant opioid management in primary care–a qualitative study. J Pain. 2014;15(11):1148–1155.
   PubMed Web of Science ®Google Scholar
• Matthias MS, Krebs EE, Collins LA, Bergman AA, Coffing J, Bair MJ. I'm not abusing or anything: patient-physician communication about opioid treatment in chronic pain. Patient. Educ Couns. 2013;93(2):197–202.
   PubMed Web of Science ®Google Scholar
• Davis CS, Carr D. Physician continuing education to reduce opioid misuse, abuse, and overdose: many opportunities, few requirements. Drug Alcohol Depend. 2016;163:100–107.
   PubMed Web of Science ®Google Scholar
• Mendoza S, Rivera-Cabrero AS, Hansen H. Shifting blame: buprenorphine prescribers, addiction treatment, and prescription monitoring in middle-class America. Transcult Psychiatry. 2016;53(4):465–487.
   PubMed Web of Science ®Google Scholar
• Hurstak EE, Kushel M, Chang J, et al. The risks of opioid treatment: perspectives of primary care practitioners and patients from safety-net clinics. Subst Abus. 2017;38(2):213–221.
   PubMed Web of Science ®Google Scholar
• Stengel C. The risk of being “too honest”: drug use, stigma and pregnancy. Health Risk Soc. 2014;16(1):36–50.
   Web of Science ®Google Scholar
• Shapiro B, Coffa D, McCance-Katz EF. A primary care approach to substance misuse. Am Fam Physician. 2013;88(2):113–121.
   PubMed Web of Science ®Google Scholar
• Guest GS, MacQueen KM, Namey EE. Applied Thematic Analysis. Thousand Oaks, CA: Sage Publications; 2011.
   Google Scholar
• Netherland J, Hansen H. White opioids: pharmaceutical race and the war on drugs that wasn't. Biosocieties. 2017;12(2):217–238.
   PubMed Web of Science ®Google Scholar
• Joynt M, Train MK, Robbins BW, Halterman JS, Caiola E, Fortuna RJ. The impact of neighborhood socioeconomic status and race on the prescribing of opioids in emergency departments throughout the United States. J Gen Intern Med. 2013;28(12):1604–1610.
   PubMed Web of Science ®Google Scholar
• Rudd RA, Aleshire N, Zibbell JE, Gladden RM. Increases in drug and opioid overdose deaths-United States, 2000–2014. MMWR Morb Mortal Wkly Rep. 2016;64(50-51):1378–1382.
   PubMed Web of Science ®Google Scholar
• Roose R, Fuentes L, Cheema M. Messages about methadone and buprenorphine in reality television: a content analysis of celebrity rehab with Dr. Drew. Subst Use Misuse. 2012;47(10):1117–1124.
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration. A Guide to Substance Abuse Services for Primary Care Clinician. Rockville, MD: United States Department of Health and Human Services; 2008.
   Google Scholar
• Centers for Disease Control and Prevention. Checking the PDMP: An Important Step to Improving Opioid Prescribing Practices. cdc.gov. https://www.cdc.gov/drugoverdose/pdf/pdmp_factsheet-a.pdf. Updated August 30, 2017. Accessed October 10, 2017.
   Google Scholar
• Substance Abuse and Mental Health Services Administration. Prescription Drug Monitoring Programs: A Guide for Healthcare Providers. In Brief. 2017;10(1).
   Google Scholar
• Komaromy M, Duhigg D, Metcalf A, et al. Project ECHO (Extension for Community Healthcare Outcomes): a new model for educating primary care providers about treatment of substance use disorders. Subst Abus. 2016;37(1):20–24.
   PubMed Web of Science ®Google Scholar
• Neufeld KJ, Alvanzo A, King VL, et al. A collaborative approach to teaching medical students how to screen, intervene, and treat substance use disorders. Subst. Abus 2012;33(3):286–291.
   PubMed Web of Science ®Google Scholar
• Parish SJ, Ramaswamy M, Stein MR, Kachur EK, Arnsten JH. Teaching about substance abuse with objective structured clinical exams. J Gen Intern Med. 2006;21(5):453–459.
   PubMed Web of Science ®Google Scholar
• Kunins HV, Sohler NL, Giovanniello A, Thompson D, Cunningham CO. A buprenorphine education and training program for primary care residents: implementation and evaluation. Subst Abus. 2013;34(3):242–247.
   PubMed Web of Science ®Google Scholar
• Jaworsky D, Gardner S, Thorne JG, et al. The role of people living with HIV as patient instructors – reducing stigma and improving interest around HIV care among medical students. AIDS Care. 2017;29(4):524–531.
   PubMed Web of Science ®Google Scholar
• Guba EG. Criteria for assessing the trustworthiness of naturalistic inquiries. Ed Comm Tech 1981;29(2):75–91.
   Web of Science ®Google Scholar
• Jena AB, Press VG, Arora VM. Social desirability bias in self-rated presenteeism among resident physicians–reply. JAMA Intern Med 2013;173(2):166.
   PubMed Web of Science ®Google Scholar